From cc29f28aec7107733d961f137aea7983f987ba15 Mon Sep 17 00:00:00 2001 From: HamsaiyniVenkatesh Date: Thu, 11 Jul 2024 14:46:21 +0200 Subject: [PATCH 01/27] Updated vaccine dataset and checked grammar (EN) The latest vaccine dataset was added to blobserver. The link to the dataset on blobserver for vaccines was updated for all instances on the file and checked grammar for English version of the page. --- content/english/dashboards/vaccines.md | 12 ++++++------ 1 file changed, 6 insertions(+), 6 deletions(-) diff --git a/content/english/dashboards/vaccines.md b/content/english/dashboards/vaccines.md index 0e36907c..836bfd0d 100644 --- a/content/english/dashboards/vaccines.md +++ b/content/english/dashboards/vaccines.md @@ -49,9 +49,9 @@ For more information on vaccination in Sweden, please also see the [RECOVAC dash
The visualisations on this page were last updated: 2023-03-24.
-The [Swedish Health Agency (Folkhälsomyndigheten, FoHM)](https://folkhalsomyndigheten.se) provide information, summary statistics, and data related to COVID-19 vaccination in Sweden [(only available in Swedish)](https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/vaccinationsstatistik/statistik-for-vaccination-mot-covid-19/). The visualisations below are based on the publicly available COVID-19 vaccination data from FoHM, which can be [downloaded directly](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). For each visualisation, we describe which data in the dataset were used, how calculations were completed, and provide a link to the script(s) used to produce it. +The [Swedish Health Agency (Folkhälsomyndigheten, FoHM)](https://folkhalsomyndigheten.se) provide information, summary statistics, and data related to COVID-19 vaccination in Sweden [(only available in Swedish)](https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/vaccinationsstatistik/statistik-for-vaccination-mot-covid-19/). The visualisations below are based on the publicly available COVID-19 vaccination data from FoHM, which can be [downloaded directly](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). For each visualisation, we describe which data in the dataset were used, how calculations were completed, and provide a link to the script(s) used to produce it. -The source data is updated weekly (on Thursdays), and the visualisations on this page will be updated shortly thereafter (usually on Fridays). All of our code related to this page is available on [GitHub](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/tree/main/Vaccine_page). All of the vaccine data is processed using a single [data preparation script](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/blob/main/Vaccine_page/vaccine_dataprep_Swedentots.py). The code required to generate each visualisation/number set is linked close to the corresponding plot/text. + All of our code related to this page is available on [GitHub](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/tree/main/Vaccine_page). All of the vaccine data is processed using a single [data preparation script](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/blob/main/Vaccine_page/vaccine_dataprep_Swedentots.py). The code required to generate each visualisation/number set is linked close to the corresponding plot/text. ### General summary statistics @@ -65,7 +65,7 @@ In the chart below, we show vaccine coverage as calculated using the 'whole popu Please note, we refer to the number of doses administered (at least) for simplicity. However, other sources may use specific names/classifications to refer to different doses. For example, individuals given at least 2 doses may be considered 'fully vaccinated'. The third dose is also sometimes referred to as a 'booster dose'. Individuals with at least 3 doses are thus sometimes said to be 'fully vaccinated with a booster dose'. Other variations also exist, and other terms may arise as subsequent doses becomes more widely available. -Vaccination data is spread between multiple tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). For calculations done using the 'eligible population method', we used percentage data from the 'Vaccinerade tidsserie', 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). These tabs contained data about the amount of individuals that received at least one or two doses, at least 3 doses, at least 4 doses, and at least 5 doses, respectively. For the 'whole population method', we use the latest population data from [Statistics Sweden (SCB)](https://www.scb.se/) and the most recent 'raw number' of the doses administered from same tabs in the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). +Vaccination data is spread between multiple tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). For calculations done using the 'eligible population method', we used percentage data from the 'Vaccinerade tidsserie', 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). These tabs contained data about the amount of individuals that received at least one or two doses, at least 3 doses, at least 4 doses, and at least 5 doses, respectively. For the 'whole population method', we use the latest population data from [Statistics Sweden (SCB)](https://www.scb.se/) and the most recent 'raw number' of the doses administered from same tabs in the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). **Note on the graph:** Click on the coloured squares in the legend of the below graph to toggle which datasets are displayed. A single click will toggle just that dataset on/off. It is possible to display only one of the datasets by double-clicking on the desired dataset. @@ -83,7 +83,7 @@ To summarise, in total, % of the population In Sweden, the first vaccine doses were administered in early 2021. As in other countries, the first two doses were made available to progressively younger age groups over time. The third dose of the vaccine was first offered in autumn of 2021, and was offered to individuals in particular ages groups at a given interval after their second dose. The age group and interval length differed over time, with age groups generally getting younger and the interval becoming shorter. A third dose is not offered to those under 18 years of age, unless there are additional considerations e.g. the individual is immunocompromised. In early 2022, a fourth dose was made available to those aged over 80, those receiving care, those living in housing facilities for the elderly, and those with severe immunodeficiency. This was extended to include those over 65 in April 2022. As of September 2022, it was made largely available to those over 18, though the availability varied between counties. At each stage of the rollout of the fourth dose, exceptions were made so that others could get the fourth dose under specific circumstances, for example, where an individual is immunocompromised or taking care of a vulnerable individual. A fifth dose was made available to those over 65 in September 2022 and, as with the other doses, it is likely to be made available to more of the population over time and other groups are able to access it under certain conditions. -Time series data is available in different tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). We therefore took data from different places to produce the below time series. Time series data related to the amount of individuals that have received at least one or two doses is available in the 'Vaccinerade tidsserie' tab. Time series data about the amount of individuals that have at least 3, 4, or 5 doses is available in the 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs, respectively. Again, please note that it would not be appropriate to compare across all of the dose levels, both because the vaccines are not similarly available and because FoHM do not include all of the doses administered in their data. Firstly, a dose is only 'counted' in the FoHM data if it is administered to an individual within a specific age range. Data on the first on second doses is only included for individuals born in or before 2010 (around 12 years old). Data on the third and fourth doses is only included for individuals born in or before 2004 (around 18 years old). Data on the fifth dose is only included if it was given to an individual born in or before 1957 (around 65 years old). There are also some other caveats about whether a dose is 'counted' in the data file. In particular, data on the third dose is only included if it was registered after 1st September 2021 and at least 8 weeks after the individual received their second dose. Similarly, data on the fourth dose is only included if it was registered after 21st January 2022 and at least 8 weeks after the individual received their third dose. Lastly, data on dose 5 is only included if the dose was registerd after 15th August 2022 and was received at least 80 days after the individual received dose 4. +Time series data is available in different tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). We therefore took data from different places to produce the below time series. Time series data related to the amount of individuals that have received at least one or two doses is available in the 'Vaccinerade tidsserie' tab. Time series data about the amount of individuals that have at least 3, 4, or 5 doses is available in the 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs, respectively. Again, please note that it would not be appropriate to compare across all of the dose levels, both because the vaccines are not similarly available and because FoHM do not include all of the doses administered in their data. Firstly, a dose is only 'counted' in the FoHM data if it is administered to an individual within a specific age range. Data on the first on second doses is only included for individuals born in or before 2010 (around 12 years old). Data on the third and fourth doses is only included for individuals born in or before 2004 (around 18 years old). Data on the fifth dose is only included if it was given to an individual born in or before 1957 (around 65 years old). There are also some other caveats about whether a dose is 'counted' in the data file. In particular, data on the third dose is only included if it was registered after 1st September 2021 and at least 8 weeks after the individual received their second dose. Similarly, data on the fourth dose is only included if it was registered after 21st January 2022 and at least 8 weeks after the individual received their third dose. Lastly, data on dose 5 is only included if the dose was registerd after 15th August 2022 and was received at least 80 days after the individual received dose 4. The below graph shows vaccine coverage across the whole of Sweden. We use the 'whole population' method for calculation, as this is more often used by other countries. Our calculations will therefore differ from the percentage values provided by FoHM as part of their summary statistics, because they use the 'eligible population' method of calculation. For more details on the two methods, see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section. @@ -97,7 +97,7 @@ The below graph shows vaccine coverage across the whole of Sweden. We use the 'w ### Administration of vaccinations in each Swedish county (län) -In this section, we explore how many individuals in a given Swedish county (län) had at least X vaccine doses. Here, we again use the 'whole population' method of calculation (see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section for details). Data on the total number of people in each county was taken from [Statistics Sweden (SCB)](https://www.scb.se/en/finding-statistics/statistics-by-subject-area/population/population-composition/population-statistics/). Data on the amount of individuals given at least one or two doses in each county was taken from the 'Vaccinerade tidsserie' tab of the [data from FoHM](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). As mentioned in previous sections, only doses given to individuals born in or before 2010 (around 12 years old) are counted. Data on the amount of individuals given at least 3 or 4 doses (available in the 'Vaccinerade tidsserie dos 3' and 'Vaccinerade tidsserie dos 4' tabs of the [FoHM data](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data), respectively) is only given for those born bore 2004 (around 18 years old) and in accordance with specific timeframes and registration timepoints. Data on the fifth dose (available in the 'Vaccinerade tidsserie dos 5' tab of the [FoHM data](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data)) is only available for those born before 1957 (around 65 years old), and in accordance with certain timeframes. Given the differences in which data is 'counted' for each dose, it is clear that data should not be compared across doses. +In this section, we explore how many individuals in a given Swedish county (län) had at least X vaccine doses. Here, we again use the 'whole population' method of calculation (see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section for details). Data on the total number of people in each county was taken from [Statistics Sweden (SCB)](https://www.scb.se/en/finding-statistics/statistics-by-subject-area/population/population-composition/population-statistics/). Data on the amount of individuals given at least one or two doses in each county was taken from the 'Vaccinerade tidsserie' tab of the [data from FoHM](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). As mentioned in previous sections, only doses given to individuals born in or before 2010 (around 12 years old) are counted. Data on the amount of individuals given at least 3 or 4 doses (available in the 'Vaccinerade tidsserie dos 3' and 'Vaccinerade tidsserie dos 4' tabs of the [FoHM data](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx), respectively) is only given for those born before 2004 (around 18 years old) and in accordance with specific timeframes and registration timepoints. Data on the fifth dose (available in the 'Vaccinerade tidsserie dos 5' tab of the [FoHM data](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx)) is only available for those born before 1957 (around 65 years old), and in accordance with certain timeframes. Given the differences in which data is 'counted' for each dose, it is clear that data should not be compared across doses. As data for the fifth dose is available to such a small amount of the population, we have decided to analyse the data using both the 'whole population' and 'eligible population' methods. We feel that this will allow a clearer understanding of the differences between län in terms of the coverage for the fourth dose. @@ -154,7 +154,7 @@ Please note the differences between the two below maps. Coverage appears to be v The below heatmap provides some indication of the vaccine coverage across different age groups. The data for this **heatmap differs from that in the previous visualisations**. Specifically, instead of showing the number of people with 'at least X doses', the heatmap shows the number of people in Sweden in each age group that have been given **that specific number of doses**. For example, rather than showing the amount of people with 'at least one dose', we show the number that have had 'only one dose'. Understandably, the number that have received ONLY one dose is relatively low across all age groups; individuals that have taken one dose are naturally more likely to take subsequent doses when they become eligible to do so. Given that individuals in more advanced age categories are eligible to take more doses, coverage is likely to be higher at a greater dose level. Age groups that have only recently become eligible for a given dose level are likely to initially show low coverage. -The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data)). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. +The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx)). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. The 'eligible population method' was used in this case, as it would not be appropriate to consider the whole population when considering vaccination coverage within specific age groups. From e038b2c5fee7f5b3b09d385f4acd184f8d22a272 Mon Sep 17 00:00:00 2001 From: HamsaiyniVenkatesh Date: Thu, 11 Jul 2024 15:06:36 +0200 Subject: [PATCH 02/27] Updated vaccine dataset and checked grammar (SV) The vaccine dataset was uploaded to blobserver. The link to the vaccine dataset is updated to the latest dataset on blobserver for all the instances in the webpage and checked grammar for the Swedish Webpage. Also includes a minor change/update on EN file. --- content/english/dashboards/vaccines.md | 2 +- content/svenska/dashboards/vaccines.md | 12 ++++++------ 2 files changed, 7 insertions(+), 7 deletions(-) diff --git a/content/english/dashboards/vaccines.md b/content/english/dashboards/vaccines.md index 836bfd0d..4d87eeac 100644 --- a/content/english/dashboards/vaccines.md +++ b/content/english/dashboards/vaccines.md @@ -154,7 +154,7 @@ Please note the differences between the two below maps. Coverage appears to be v The below heatmap provides some indication of the vaccine coverage across different age groups. The data for this **heatmap differs from that in the previous visualisations**. Specifically, instead of showing the number of people with 'at least X doses', the heatmap shows the number of people in Sweden in each age group that have been given **that specific number of doses**. For example, rather than showing the amount of people with 'at least one dose', we show the number that have had 'only one dose'. Understandably, the number that have received ONLY one dose is relatively low across all age groups; individuals that have taken one dose are naturally more likely to take subsequent doses when they become eligible to do so. Given that individuals in more advanced age categories are eligible to take more doses, coverage is likely to be higher at a greater dose level. Age groups that have only recently become eligible for a given dose level are likely to initially show low coverage. -The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx)). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. +The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. The 'eligible population method' was used in this case, as it would not be appropriate to consider the whole population when considering vaccination coverage within specific age groups. diff --git a/content/svenska/dashboards/vaccines.md b/content/svenska/dashboards/vaccines.md index 796bf87e..c640ba41 100644 --- a/content/svenska/dashboards/vaccines.md +++ b/content/svenska/dashboards/vaccines.md @@ -48,9 +48,9 @@ For more information on vaccination in Sweden, please also see the [RECOVAC dash
The visualisations on this page were last updated: 2023-03-24.
-The [Swedish Health Agency (Folkhälsomyndigheten, FoHM)](https://folkhalsomyndigheten.se) provide information, summary statistics, and data related to COVID-19 vaccination in Sweden [(only available in Swedish)](https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/vaccinationsstatistik/statistik-for-vaccination-mot-covid-19/). The visualisations below are based on the publicly available COVID-19 vaccination data from FoHM, which can be [downloaded directly](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). For each visualisation, we describe which data in the dataset were used, how calculations were completed, and provide a link to the script(s) used to produce it. +The [Swedish Health Agency (Folkhälsomyndigheten, FoHM)](https://folkhalsomyndigheten.se) provide information, summary statistics, and data related to COVID-19 vaccination in Sweden [(only available in Swedish)](https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/vaccinationsstatistik/statistik-for-vaccination-mot-covid-19/). The visualisations below are based on the publicly available COVID-19 vaccination data from FoHM, which can be [downloaded directly](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). For each visualisation, we describe which data in the dataset were used, how calculations were completed, and provide a link to the script(s) used to produce it. -The source data is updated weekly (on Thursdays), and the visualisations on this page will be updated shortly thereafter (usually on Fridays). All of our code related to this page is available on [GitHub](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/tree/main/Vaccine_page). All of the vaccine data is processed using a single [data preparation script](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/blob/main/Vaccine_page/vaccine_dataprep_Swedentots.py). The code required to generate each visualisation/number set is linked close to the corresponding plot/text. + All of our code related to this page is available on [GitHub](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/tree/main/Vaccine_page). All of the vaccine data is processed using a single [data preparation script](https://github.com/ScilifelabDataCentre/pathogens-portal-visualisations/blob/main/Vaccine_page/vaccine_dataprep_Swedentots.py). The code required to generate each visualisation/number set is linked close to the corresponding plot/text. ### General summary statistics @@ -64,7 +64,7 @@ In the chart below, we show vaccine coverage as calculated using the 'whole popu Please note, we refer to the number of doses administered (at least) for simplicity. However, other sources may use specific names/classifications to refer to different doses. For example, individuals given at least 2 doses may be considered 'fully vaccinated'. The third dose is also sometimes referred to as a 'booster dose'. Individuals with at least 3 doses are thus sometimes said to be 'fully vaccinated with a booster dose'. Other variations also exist, and other terms may arise as subsequent doses becomes more widely available. -Vaccination data is spread between multiple tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). For calculations done using the 'eligible population method', we used percentage data from the 'Vaccinerade tidsserie', 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). These tabs contained data about the amount of individuals that received at least one or two doses, at least 3 doses, at least 4 doses, and at least 5 doses, respectively. For the 'whole population method', we use the latest population data from [Statistics Sweden (SCB)](https://www.scb.se/) and the most recent 'raw number' of the doses administered from same tabs in the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). +Vaccination data is spread between multiple tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). For calculations done using the 'eligible population method', we used percentage data from the 'Vaccinerade tidsserie', 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). These tabs contained data about the amount of individuals that received at least one or two doses, at least 3 doses, at least 4 doses, and at least 5 doses, respectively. For the 'whole population method', we use the latest population data from [Statistics Sweden (SCB)](https://www.scb.se/) and the most recent 'raw number' of the doses administered from same tabs in the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). **Note on the graph:** Click on the coloured squares in the legend of the below graph to toggle which datasets are displayed. A single click will toggle just that dataset on/off. It is possible to display only one of the datasets by double-clicking on the desired dataset. @@ -82,7 +82,7 @@ To summarise, in total, % of the population In Sweden, the first vaccine doses were administered in early 2021. As in other countries, the first two doses were made available to progressively younger age groups over time. The third dose of the vaccine was first offered in autumn of 2021, and was offered to individuals in particular ages groups at a given interval after their second dose. The age group and interval length differed over time, with age groups generally getting younger and the interval becoming shorter. A third dose is not offered to those under 18 years of age, unless there are additional considerations e.g. the individual is immunocompromised. In early 2022, a fourth dose was made available to those aged over 80, those receiving care, those living in housing facilities for the elderly, and those with severe immunodeficiency. This was extended to include those over 65 in April 2022. As of September 2022, it was made largely available to those over 18, though the availability varied between counties. At each stage of the rollout of the fourth dose, exceptions were made so that others could get the fourth dose under specific circumstances, for example, where an individual is immunocompromised or taking care of a vulnerable individual. A fifth dose was made available to those over 65 in September 2022 and, as with the other doses, it is likely to be made available to more of the population over time and other groups are able to access it under certain conditions. -Time series data is available in different tabs of the [FoHM data file](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). We therefore took data from different places to produce the below time series. Time series data related to the amount of individuals that have received at least one or two doses is available in the 'Vaccinerade tidsserie' tab. Time series data about the amount of individuals that have at least 3, 4, or 5 doses is available in the 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs, respectively. Again, please note that it would not be appropriate to compare across all of the dose levels, both because the vaccines are not similarly available and because FoHM do not include all of the doses administered in their data. Firstly, a dose is only 'counted' in the FoHM data if it is administered to an individual within a specific age range. Data on the first on second doses is only included for individuals born in or before 2010 (around 12 years old). Data on the third and fourth doses is only included for individuals born in or before 2004 (around 18 years old). Data on the fifth dose is only included if it was given to an individual born in or before 1957 (around 65 years old). There are also some other caveats about whether a dose is 'counted' in the data file. In particular, data on the third dose is only included if it was registered after 1st September 2021 and at least 8 weeks after the individual received their second dose. Similarly, data on the fourth dose is only included if it was registered after 21st January 2022 and at least 8 weeks after the individual received their third dose. Lastly, data on dose 5 is only included if the dose was registerd after 15th August 2022 and was received at least 80 days after the individual received dose 4. +Time series data is available in different tabs of the [FoHM data file](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). We therefore took data from different places to produce the below time series. Time series data related to the amount of individuals that have received at least one or two doses is available in the 'Vaccinerade tidsserie' tab. Time series data about the amount of individuals that have at least 3, 4, or 5 doses is available in the 'Vaccinerade tidsserie dos 3', 'Vaccinerade tidsserie dos 4', and 'Vaccinerade tidsserie dos 5' tabs, respectively. Again, please note that it would not be appropriate to compare across all of the dose levels, both because the vaccines are not similarly available and because FoHM do not include all of the doses administered in their data. Firstly, a dose is only 'counted' in the FoHM data if it is administered to an individual within a specific age range. Data on the first on second doses is only included for individuals born in or before 2010 (around 12 years old). Data on the third and fourth doses is only included for individuals born in or before 2004 (around 18 years old). Data on the fifth dose is only included if it was given to an individual born in or before 1957 (around 65 years old). There are also some other caveats about whether a dose is 'counted' in the data file. In particular, data on the third dose is only included if it was registered after 1st September 2021 and at least 8 weeks after the individual received their second dose. Similarly, data on the fourth dose is only included if it was registered after 21st January 2022 and at least 8 weeks after the individual received their third dose. Lastly, data on dose 5 is only included if the dose was registerd after 15th August 2022 and was received at least 80 days after the individual received dose 4. The below graph shows vaccine coverage across the whole of Sweden. We use the 'whole population' method for calculation, as this is more often used by other countries. Our calculations will therefore differ from the percentage values provided by FoHM as part of their summary statistics, because they use the 'eligible population' method of calculation. For more details on the two methods, see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section. @@ -96,7 +96,7 @@ The below graph shows vaccine coverage across the whole of Sweden. We use the 'w ### Administration of vaccinations in each Swedish county (län) -In this section, we explore how many individuals in a given Swedish county (län) had at least X vaccine doses. Here, we again use the 'whole population' method of calculation (see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section for details). Data on the total number of people in each county was taken from [Statistics Sweden (SCB)](https://www.scb.se/en/finding-statistics/statistics-by-subject-area/population/population-composition/population-statistics/). Data on the amount of individuals given at least one or two doses in each county was taken from the 'Vaccinerade tidsserie' tab of the [data from FoHM](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data). As mentioned in previous sections, only doses given to individuals born in or before 2010 (around 12 years old) are counted. Data on the amount of individuals given at least 3 or 4 doses (available in the 'Vaccinerade tidsserie dos 3' and 'Vaccinerade tidsserie dos 4' tabs of the [FoHM data](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data), respectively) is only given for those born bore 2004 (around 18 years old) and in accordance with specific timeframes and registration timepoints. Data on the fifth dose (available in the 'Vaccinerade tidsserie dos 5' tab of the [FoHM data](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data)) is only available for those born before 1957 (around 65 years old), and in accordance with certain timeframes. Given the differences in which data is 'counted' for each dose, it is clear that data should not be compared across doses. +In this section, we explore how many individuals in a given Swedish county (län) had at least X vaccine doses. Here, we again use the 'whole population' method of calculation (see the [general summary statistics](/dashboards/vaccines/#general-summary-statistics) section for details). Data on the total number of people in each county was taken from [Statistics Sweden (SCB)](https://www.scb.se/en/finding-statistics/statistics-by-subject-area/population/population-composition/population-statistics/). Data on the amount of individuals given at least one or two doses in each county was taken from the 'Vaccinerade tidsserie' tab of the [data from FoHM](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). As mentioned in previous sections, only doses given to individuals born in or before 2010 (around 12 years old) are counted. Data on the amount of individuals given at least 3 or 4 doses (available in the 'Vaccinerade tidsserie dos 3' and 'Vaccinerade tidsserie dos 4' tabs of the [FoHM data](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx), respectively) is only given for those born before 2004 (around 18 years old) and in accordance with specific timeframes and registration timepoints. Data on the fifth dose (available in the 'Vaccinerade tidsserie dos 5' tab of the [FoHM data](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx)) is only available for those born before 1957 (around 65 years old), and in accordance with certain timeframes. Given the differences in which data is 'counted' for each dose, it is clear that data should not be compared across doses. As data for the fifth dose is available to such a small amount of the population, we have decided to analyse the data using both the 'whole population' and 'eligible population' methods. We feel that this will allow a clearer understanding of the differences between län in terms of the coverage for the fourth dose. @@ -153,7 +153,7 @@ Please note the differences between the two below maps. Coverage appears to be v The below heatmap provides some indication of the vaccine coverage across different age groups. The data for this **heatmap differs from that in the previous visualisations**. Specifically, instead of showing the number of people with 'at least X doses', the heatmap shows the number of people in Sweden in each age group that have been given **that specific number of doses**. For example, rather than showing the amount of people with 'at least one dose', we show the number that have had 'only one dose'. Understandably, the number that have received ONLY one dose is relatively low across all age groups; individuals that have taken one dose are naturally more likely to take subsequent doses when they become eligible to do so. Given that individuals in more advanced age categories are eligible to take more doses, coverage is likely to be higher at a greater dose level. Age groups that have only recently become eligible for a given dose level are likely to initially show low coverage. -The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://fohm.maps.arcgis.com/sharing/rest/content/items/fc749115877443d29c2a49ea9eca77e9/data)). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. +The fact that data is not available for each age category for every dose is reflected in the graph (a white colouration is used to indicate where data is not available/included). Data on the first three doses are available in the 'Dos 1 till 3 per åldersgrupp' tab of the [FoHM dataset](https://blobserver.dc.scilifelab.se/blob/Folkhalsomyndigheten_Covid19_Vaccine-93.xlsx). Data on the fourth and fifth doses are instead available in the 'Dos 4 18+' and 'Dos 5 per åldersgrupp' tabs, respectively. The 'eligible population method' was used in this case, as it would not be appropriate to consider the whole population when considering vaccination coverage within specific age groups. From c092a976e7c6e81069b11759180cc1cc305bf05e Mon Sep 17 00:00:00 2001 From: Ziip-dev <62331138+Ziip-dev@users.noreply.github.com> Date: Wed, 17 Jul 2024 14:31:21 +0200 Subject: [PATCH 03/27] Add update date placeholder in dashboard cards - Get dashboard file URL path in Hugo template - Add a
element with the necessary paging classes - Add a element with an 'id' property to easily address the different dashboard cards --- layouts/partials/dashboards.html | 6 +++++- 1 file changed, 5 insertions(+), 1 deletion(-) diff --git a/layouts/partials/dashboards.html b/layouts/partials/dashboards.html index 6c6e546a..b534e06c 100644 --- a/layouts/partials/dashboards.html +++ b/layouts/partials/dashboards.html @@ -4,7 +4,7 @@ {{ $displayed_in_homepage := .IsHome }} {{ $dashboards_to_show := slice }} -{{/* Compile list of highlight to show depending upon the page */}} +{{/* Compile list of dashboards to show depending upon the page */}} {{ if eq $currentPage.File "dashboards" }} {{ $dashboards_to_show = $dashboards_to_show | append (where $dashboards "Identifier" "ne" "all_dashboards") }} {{ else if $displayed_in_homepage }} @@ -22,6 +22,7 @@
{{ range $dashboards_to_show }} + {{ $dashboardPage := path.Split (path.Clean .Page.RelPermalink) }}
@@ -35,6 +36,9 @@
{{ .Name }}
+ Updated: +
+
{{ .Page.Description }}
{{ if not $displayed_in_homepage }} From 9f69943544a4d305280a0792d371aa8a78ce7b72 Mon Sep 17 00:00:00 2001 From: HamsaiyniVenkatesh Date: Tue, 23 Jul 2024 16:13:35 +0200 Subject: [PATCH 04/27] Updated ABR ongoing project information (Formas) The details of highlighted ongoing projects from the Formas tab in the excel file has been formatted in JSON and added to this update. --- data/research_projects.json | 78 +++++++++++++++++++++++++++++++++++++ 1 file changed, 78 insertions(+) diff --git a/data/research_projects.json b/data/research_projects.json index 0723bdc5..38fbd05b 100644 --- a/data/research_projects.json +++ b/data/research_projects.json @@ -1,6 +1,84 @@ { "last_updated": "2023-03-06", "projects": [ + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "A comprehensive assessment of the impact of Campylobacter positive broilers on human infection – from farm to molecular epidemiology", + "funding_amount": "2,962,992 kr", + "pi": "Wonhee Cha", + "pi_affiliation": "National Veterinary Institute, SVA", + "startdate": "2020-01-01", + "enddate": "2022-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2019-01541_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "Curbing the emergence of antimicrobial resistance in a changing global livestock sector", + "funding_amount": "2,976,633 kr", + "pi": "Ulf Magnusson", + "pi_affiliation": "Swedish University of Agricultural Sciences", + "startdate": "2019-01-01", + "enddate": "2021-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2018-01093_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "DisPersal of AntIbiotic Resistance and antibiotics in Water ecosystems and Influence on liveStock and aquatic wildlifE", + "funding_amount": "3,226,000 kr", + "pi": "Jonas Bonnedahl", + "pi_affiliation": "Linköping University", + "startdate": "2021-06-01", + "enddate": "2024-05-31 00:00:00", + "url": "https://www.vr.se/english/swecris.html#/project/2020-03193_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "Genotyping for better knowledge o spread, virulence and resistance of coagulase negative staphylococci from cases of mastitis in dairy cows including zoonotic aspects", + "funding_amount": "2,879,280 kr", + "pi": "Karin Persson Waller", + "pi_affiliation": "National Veterinary Institute, SVA", + "startdate": "2019-01-01", + "enddate": "2021-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2018-01043_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "Invertebrates as vectors of antimicrobial resistance genes in urban landscapes", + "funding_amount": "2,998,910 kr", + "pi": "Richard Svanbäck", + "pi_affiliation": "Uppsala University", + "startdate": "2024-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2023-01420_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "Metagenomic time travel to study the evolution of antimicrobial resistance in microbiomes of wild Swedish mammals", + "funding_amount": "3,000,000 kr", + "pi": "Katerina Guschanski", + "pi_affiliation": "Uppsala University", + "startdate": "2020-01-01", + "enddate": "2022-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2019-00275_Formas" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Formas", + "project_title": "Microsystem with electrical sensing of bacteria – a novel rapid diagnostic test", + "funding_amount": "2,989,847 kr", + "pi": "Maria Tenje", + "pi_affiliation": "Uppsala University", + "startdate": "2023-01-01", + "enddate": "2025-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-01032_Formas" + } + { "topic": [ "COVID-19", From e94ae3ec1c19fc3248c406e26f546f8cccaf71f7 Mon Sep 17 00:00:00 2001 From: HamsaiyniVenkatesh Date: Tue, 23 Jul 2024 16:17:44 +0200 Subject: [PATCH 05/27] Updated ABR ongoing project information (Vinnova) The details from the highlighted ongoing projects from the Vinnova tab is updated here. --- data/research_projects.json | 55 +++++++++++++++++++++++++++++++++++++ 1 file changed, 55 insertions(+) diff --git a/data/research_projects.json b/data/research_projects.json index 38fbd05b..d69c1cce 100644 --- a/data/research_projects.json +++ b/data/research_projects.json @@ -1,6 +1,61 @@ { "last_updated": "2023-03-06", "projects": [ + { + "topic": ["Antibiotic resistance"], + "funder": "Vinnova", + "project_title": "A new, safe and resistance-free treatment of vaginal fungal and bacterial infections", + "funding_amount": "3,000,000 kr", + "pi": "Annette SÄFHOLM", + "pi_affiliation": "GEDEA BIOTECH AB", + "startdate": "2023-04-01", + "enddate": "2024-06-30", + "url": "https://www.vr.se/english/swecris.html#/project/2022-03444_Vinnova" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Vinnova", + "project_title": "Development of a novel interferon-based therapy to treat and prevent bacterial and viral infections", + "funding_amount": "4,999,997 kr", + "pi": "Irina Zaitseva", + "pi_affiliation": "FarmPharma AB (publ)", + "startdate": "2021-10-01", + "enddate": "2025-03-31", + "url": "https://www.vr.se/english/swecris.html#/project/2021-03284_Vinnova" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Vinnova", + "project_title": "EbsArgent® development", + "funding_amount": "1,960,710 kr", + "pi": "Elias Arnér", + "pi_affiliation": “Thioredoxin Systems AB”, + "startdate": "2022-03-01", + "enddate": "2024-03-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-00526_Vinnova" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Vinnova", + "project_title": "Microcalorimetrics for precision diagnostics of orthopaedic infections (CAL- ORTHO)", + "funding_amount": "1,400,000 kr", + "pi": "Marta Veses Garcia", + "pi_affiliation": "SYMCEL SVERIGE AB", + "startdate": "2023-05-01", + "enddate": "2025-03-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-03477_Vinnova" + } + { + "topic": ["Antibiotic resistance"], + "funder": "Vinnova", + "project_title": "Strategies against antibiotic resistance in Mycobacterium tuberculosis and ESKAPE pathogens", + "funding_amount": "4,420,000 kr", + "pi": "Robert Schnell", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2017-09-01", + "enddate": "2020-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2017-00103_Vinnova" + } { "topic": ["Antibiotic resistance"], "funder": "Formas", From 3d35a8749a6fc571b5a2ca8deff6dc1e2c3d4445 Mon Sep 17 00:00:00 2001 From: HamsaiyniVenkatesh Date: Tue, 23 Jul 2024 16:33:10 +0200 Subject: [PATCH 06/27] Updated ABR ongoing project information (SRC) The details of the highlighted ongoing projects for the Swedish Research Council(SRC)tab is updated here. Also includes the update on last updated date and minor formating errors from previous commits updated. --- data/research_projects.json | 259 ++++++++++++++++++++++++++++++++++-- 1 file changed, 245 insertions(+), 14 deletions(-) diff --git a/data/research_projects.json b/data/research_projects.json index d69c1cce..6c31b620 100644 --- a/data/research_projects.json +++ b/data/research_projects.json @@ -1,6 +1,237 @@ { - "last_updated": "2023-03-06", + "last_updated": "2024-07-23", "projects": [ + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Bacterial Injection Machines within the Human Gut: Structure, Function and Potential as Novel Avenue in Precision Medicine to Battle Antimicrobial Resistance", + "funding_amount": "6,000,000 kr", + "pi": "Eva Maria Rebrova (Steiner)", + "pi_affiliation": "Lund University", + "startdate": "2023-12-01", + "enddate": "2027-11-30", + "url": "https://www.vr.se/english/swecris.html#/project/2023-02264_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Curing Sepsis - a personalized bench-to bedside approach for prediction and treatment of short and long-term complication in sepsis", + "funding_amount": "2,400,000 kr", + "pi": "Adam Linder", + "pi_affiliation": "Lund University", + "startdate": "2024-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2023-02707_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "DELIVER: An Accelerated Antibiotic Screening Platform", + "funding_amount": "2,400,000 kr", + "pi": "Anders Karlén", + "pi_affiliation": "Uppsala University", + "startdate": "2023-01-01", + "enddate": "2025-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-00654_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Development of a molecular kit for the simplified detection of phenotypic antimicrobial resistance.", + "funding_amount": "1,998,241 kr", + "pi": "Vicente Jose Pelechano Garcia", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2022-12-01", + "enddate": "2024-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-05272_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "ENABLE-2, a platform for antibacterial drug development", + "funding_amount": "100,000,000 kr", + "pi": "Anders Karlén", + "pi_affiliation": "Uppsala University", + "startdate": "2021-07-01", + "enddate": "2024-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2021-06603_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Engineering of oligonucleotides for developing first-in-class antibiotics", + "funding_amount": "4,060,000 kr", + "pi": "Frank J. Hernandez", + "pi_affiliation": "Linköping University", + "startdate": "2022-01-01", + "enddate": "2025-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2021-05641_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Epidermal Bioelectronics for Infection Monitoring in Human Skin Wound", + "funding_amount": "6,000,000 kr", + "pi": "Onur Parlak", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2023-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-01436_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Evolution and plasticity of cyclic di-nucleotide signaling networks in Bacteria", + "funding_amount": "3,200,000 kr", + "pi": "Ute Römling", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2023-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-04865_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "IDAR-Neo - Identification and characterization of fecal carriage of antimicrobial resistant bacteria in neonates in low-resource settings", + "funding_amount": "4,500,000 kr", + "pi": "Fredrik Westerlund", + "pi_affiliation": "Chalmers University of Technology", + "startdate": "2023-01-01", + "enddate": "2025-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-03490_VR" + }, + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Identification of a Novel non-antibiotic Bactericidal agent to fight antimicrobial resistance", + "funding_amount": "5,000,000 kr", + "pi": "Shilpa Ray", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2023-01-01", + "enddate": "2025-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-00500_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Immunobiology of MAIT cells in the healthy and infected human host", + "funding_amount": "9,000,000 kr", + "pi": "Johan Sandberg", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2023-12-01", + "enddate": "2028-11-30", + "url": "https://www.vr.se/english/swecris.html#/project/2023-02857_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Impact of transformation products of antimicrobial chemicals on the emergence of antimicrobial resistance in aquatic environments", + "funding_amount": "3,766,000 kr", + "pi": "Foon Yin Lai", + "pi_affiliation": "Swedish University of Agricultural Sciences", + "startdate": "2021-01-01", + "enddate": "2024-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2020-03675_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Informing genomic surveillance by uncovering, phenotyping and prioritising resistance genes to new antibiotics", + "funding_amount": "3,500,000 kr", + "pi": "Anne Farewell", + "pi_affiliation": "University of Gothenburg", + "startdate": "2024-01-01", + "enddate": "2026-12-31", + "url": "" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Nanoengineered precision therapies of lower respiratory tract infections", + "funding_amount": "30,000,000 kr", + "pi": "Georgios Sotiriou", + "pi_affiliation": "Karolinska Institutet", + "startdate": "2022-01-01", + "enddate": "2027-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2021-02059_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Novel strategies to treat serious infectious diseases and combat antimicrobial resistance", + "funding_amount": "5,600,000 kr", + "pi": "Kristian Riesbeck", + "pi_affiliation": "Lund University", + "startdate": "2011-01-01", + "enddate": "2014-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2010-04221_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Proof-of-concept design of multivalent nanoparticle vaccines against antibiotic-resistant bacteria", + "funding_amount": "1,992,738 kr", + "pi": "Johan Malmström", + "pi_affiliation": "Lund University", + "startdate": "2022-12-01", + "enddate": "2024-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2022-05264_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Standardized One Health surveillance of antiBiotic residues and antibiotic and heAvy metaL resisTance In BaltiC wAter environMents and wild biRds", + "funding_amount": "1,532,000 kr", + "pi": "Jonas Waldenström", + "pi_affiliation": "Linnaeus University", + "startdate": "2024-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2023-01741_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Standardized One Health surveillance of antibiotic residues and antibiotic- and heavy metal resistance in Baltic water environments and wild birds", + "funding_amount": "1,943,000 kr", + "pi": "Jonas Bonnedahl", + "pi_affiliation": "Linköping University", + "startdate": "2024-01-01", + "enddate": "2026-12-31", + "url": "https://www.vr.se/english/swecris.html#/project/2023-01740_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "Structure, synthesis and recognition of carbohydrates and glycoconjugates", + "funding_amount": "4,267,000 kr", + "pi": "Johan Bengtsson-Palme", + "pi_affiliation": "Chalmers University of Technology", + "startdate": "2023-12-01", + "enddate": "2026-11-30", + "url": "https://www.vr.se/english/swecris.html#/project/2022-03014_VR" + }, + + { + "topic": ["Antibiotic resistance"], + "funder": "Swedish Research Council", + "project_title": "The role of the normal flora in preventing respiratory infections and antibiotic resistance spread.", + "funding_amount": "2,400,000 kr", + "pi": "Anders P Håkansson", + "pi_affiliation": "Lund University", + "startdate": "2022-12-01", + "enddate": "2025-11-30", + "url": "https://www.vr.se/english/swecris.html#/project/2022-01296_VR" + }, + { "topic": ["Antibiotic resistance"], "funder": "Vinnova", @@ -11,7 +242,7 @@ "startdate": "2023-04-01", "enddate": "2024-06-30", "url": "https://www.vr.se/english/swecris.html#/project/2022-03444_Vinnova" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Vinnova", @@ -22,18 +253,18 @@ "startdate": "2021-10-01", "enddate": "2025-03-31", "url": "https://www.vr.se/english/swecris.html#/project/2021-03284_Vinnova" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Vinnova", "project_title": "EbsArgent® development", "funding_amount": "1,960,710 kr", "pi": "Elias Arnér", - "pi_affiliation": “Thioredoxin Systems AB”, + "pi_affiliation": "Thioredoxin Systems AB", "startdate": "2022-03-01", "enddate": "2024-03-31", "url": "https://www.vr.se/english/swecris.html#/project/2022-00526_Vinnova" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Vinnova", @@ -44,7 +275,7 @@ "startdate": "2023-05-01", "enddate": "2025-03-31", "url": "https://www.vr.se/english/swecris.html#/project/2022-03477_Vinnova" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Vinnova", @@ -55,7 +286,7 @@ "startdate": "2017-09-01", "enddate": "2020-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2017-00103_Vinnova" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -66,7 +297,7 @@ "startdate": "2020-01-01", "enddate": "2022-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2019-01541_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -77,7 +308,7 @@ "startdate": "2019-01-01", "enddate": "2021-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2018-01093_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -88,7 +319,7 @@ "startdate": "2021-06-01", "enddate": "2024-05-31 00:00:00", "url": "https://www.vr.se/english/swecris.html#/project/2020-03193_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -99,7 +330,7 @@ "startdate": "2019-01-01", "enddate": "2021-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2018-01043_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -110,7 +341,7 @@ "startdate": "2024-01-01", "enddate": "2026-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2023-01420_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -121,7 +352,7 @@ "startdate": "2020-01-01", "enddate": "2022-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2019-00275_Formas" - } + }, { "topic": ["Antibiotic resistance"], "funder": "Formas", @@ -132,7 +363,7 @@ "startdate": "2023-01-01", "enddate": "2025-12-31", "url": "https://www.vr.se/english/swecris.html#/project/2022-01032_Formas" - } + }, { "topic": [ From 73c00d19e5909ee1a9a8afd8fb15a8452e8ee07c Mon Sep 17 00:00:00 2001 From: Senthilkumar Panneerselvam Date: Fri, 26 Jul 2024 09:19:10 +0200 Subject: [PATCH 07/27] Fix redundant IDs --- layouts/partials/navbar.html | 80 ++++++++++++++++++------------------ 1 file changed, 40 insertions(+), 40 deletions(-) diff --git a/layouts/partials/navbar.html b/layouts/partials/navbar.html index 678b9571..d5180f3b 100644 --- a/layouts/partials/navbar.html +++ b/layouts/partials/navbar.html @@ -105,22 +105,22 @@
- -
- -